Literature DB >> 1277724

Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acid.

I Odar-Cederlöf, O Borga.   

Abstract

The plasma protein binding of phenytoin (DPH) was studied by equilibrium dialysis at 37 degrees C in plasma from uremic patients and healthy subjects. Scatchard plot analyses demonstrated a decreased association constant Ka for the DPH-albumin interaction in the uremic plasma (mean 1.76 - 10(3) M-1 +/-SD 0.12 and a mean 4.10 - 10(3) M-1 +/- SD 0.24 in normal plasma). Studies on separated fractions of serum did not indicate any significant binding of DPH to proteins other than albumin. The nonlinear mathematical relationship between bound DPH and serum albumin could be linearized at low drug concentrations by plotting the ratio of bound/unbound DPH against albumin concentration. The displacement effect of salicylic acid at a concentration of 276 mug/ml (2mM) and DPH was considerable in plasma from normal subjects. In uremic plasma the effect was of much smaller magnitude.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1277724     DOI: 10.1002/cpt197620136

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  14 in total

Review 1.  Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid.

Authors:  J O Miners
Journal:  Clin Pharmacokinet       Date:  1989-11       Impact factor: 6.447

2.  Plasma protein binding of phenytoin and warfarin in patients undergoing renal transplantation.

Authors:  I Odar-Cederlof
Journal:  Clin Pharmacokinet       Date:  1977 Mar-Apr       Impact factor: 6.447

3.  Family study of genetic and environmental factors determining the protein binding of propranolol.

Authors:  G Alván; K Bergström; O Borgå; L Iselius; N Pedersen
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  Potentially lethal interaction of cimetidine and morphine.

Authors: 
Journal:  Can Med Assoc J       Date:  1981-12-01       Impact factor: 8.262

Review 5.  Drug interactions with phenytoin.

Authors:  E Perucca; A Richens
Journal:  Drugs       Date:  1981-02       Impact factor: 9.546

Review 6.  Pharmacokinetic interactions with antiepileptic drugs.

Authors:  E Perucca
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

Review 7.  Protein binding of cardiac glycosides in disease states.

Authors:  L Storstein
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

8.  Pharmacokinetics and clinical effects of phenytoin and fosphenytoin in children with severe malaria and status epilepticus.

Authors:  Bernhards R Ogutu; Charles R J C Newton; Simon N Muchohi; Godfrey O Otieno; Geoffrey Edwards; William M Watkins; Gilbert O Kokwaro
Journal:  Br J Clin Pharmacol       Date:  2003-07       Impact factor: 4.335

9.  Pharmacokinetics of enprofylline in patients with impaired renal function after a single intravenous dose.

Authors:  E Lunell; O Borgå; R Larsson
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 10.  Free drug concentration monitoring in clinical practice. Rationale and current status.

Authors:  C K Svensson; M N Woodruff; J G Baxter; D Lalka
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.